The AI platform combined with autonomous laboratories will accelerate discovery in all areas of science
The company has increased $ 200 million in the financing of seeds to further develop the platform and build the first AI science factories
Cambridge, mass.,, March 10, 2025 / Prnewswire / – flagship pioneering, The Bioplateform Innovation Company, has now unveiled Lila Sciences, a company building the first global scientific superintelligence platform and fully autonomous laboratories for life, chemicals and material sciences. The company, which was founded in Flatship laboratories in 2023, a pioneer an advanced form of AI which can not only process large amounts of data and make predictions, but also help scientists to design and lead new experiences, generate hypotheses and test them in real environments.
Lila raised 200 million dollars In the capital of the seeds initiated from a flagship pioneer, as well as the general catalyst, the capital of March, the venture capital fund, the altitude of life of life, Blue Horizon advisers, the state of the Michigan pension system, modification and a subsidiary in exclusive property of the Abu Dhabi Investment Authorrity (ADIA) to support the rapid development of the platform AI, autonomous laboratories and fast infractures.
“Lila’s mission to fulfill the scientific superintelligence in a responsible manner is born from the conviction that this is the most important opportunity of our time, and that the leader in this pursuit will be the entity that manages the scientific method on the largest scale, speed and intelligence,” said Geoffrey von MaltzahnPh.D., Co-founder and chief executive officer of Lila Sciences and general partner, Pioneer lighthouse. “To achieve this, we must solve difficult problems to allow AI independently and evolves to execute each step – from models of AI generating an idea to reducing practice with robotics and automation. We have made incredible progress in a few years and we are at the very beginning of this important mission.”
“For all human history, the method of scientific exploration has been constant: we predict, test, learn, create. However, for all the progress we have made, we always understand only a fraction of the rules that govern the physical world,” said Noubar AfeyanPh.D., founder and CEO of the flagship and co-founder and president, Lila Sciences. “With Lila, our hypothesis is that evolving experimentation, we can unlock emerging capacities and allow discoveries that remain hidden on a smaller scale. Lila represents an ambitious enterprise which, in our view, will accelerate science with a huge advantage for society.”
The Lila’s autonomous scientific platform is designed to, with human advice, evolve and optimize experimentation in any scientific field by combining generative AI with scientific units of generalizable, scalable and autonomous AI. In just a few years of development, the platform has demonstrated performance in several areas that go beyond the human and existing benchmarks fed by AI, in particular:
- LLMS with advanced reasoning capacities on important scientific problems and scientific intelligence references;
- Generation of optimal genetic medicine constructions that surpass the therapies available commercially;
- Discovery and validation of hundreds of new antibodies, peptides and binders for a wide range of therapeutic targets;
- Generation of unique non -platinum group metals as catalysts in the production of green hydrogen at a fraction of the cost of current commercial catalysts; And
- Design of new materials for carbon capture on an industrial scale with better capacity, thermal stability and a kinetic bond than the main products.
The Lila platform will be open to partners in the life and material science industries to jointly propose human health and sustainability solutions at a rate and on a scale beyond today’s limits.
Molly GibsonPh.D., co-founder and president, future science at Lila Sciences and Origin Partner, flagship Pionering has added: “AI has already transformed our ability to discover new ideas from existing data. We believe that the next border in scientific discovery will come to orchestrate thousands of experiences simultaneously, systematically creating our understanding and accelerating scientific progress.
Lila is led by a team that brings the depth and extent of expertise in various fields, including AI, security, commercial strategy, organizational efficiency, robotics and scientific fields covering biology, chemistry and materials. Renowned geneticist George churchPh.D., will play the role of chief scientist. Andrew beamPh.D., serves as a company CTO, building an AI research team that includes Kenneth StanleyPh.D., who joins as a main vice-president. Rafael Gómez-Bombarelli, Ph.D., joined the company as a materials CSO. Christopher FussellAn author and expert in interfunctional collaboration, is president of the company’s operations.
About Lila Sciences
Lila Sciences is the first scientific superintendent platform in the world and autonomous laboratories for life science, chemicals and materials. We pioned to a new era of unlimited discovery by strengthening the capacities to apply AI to all aspects of the scientific method. We introduce scientific superintelligence to resolve the greatest challenges of humanity, allowing scientists to offer human health and sustainability solutions at a rate and on a scale never experienced before. Lila was founded in the flagship pioneering laboratories in 2023. Find out more about this mission to www.lila.ai
On the flagship pioneer
The flagship pioneer invents and builds bioplate companies, each with potential for several products that transform human health or sustainability. Since its launch in 2000, the flagship product is from and favored more than 100 scientific companies, which has led more than $ 60 billion in global value. The flagship product works with $ 14 billion assets under management from its last capital increase, announcement In July 2024. The current flagship ecosystem includes more than 40 companies, especially Therapeutic Foghorn (Nasdaq: FHTX),, Modern (Nasdaq: Mrnm),, Sana Biotechnology (Nasdaq: Sana),, Generate biomedices,, Inari,, Indigo agricultureAnd Tessera Therapeutics.
Contact with the media
Lila Sciences
(Protected by e-mail)
Pioneer flagship source
